v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net income $ 51,852 $ 17,514
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 46,651 29,348
Amortization of debt issuance cost 3,438 2,892
Stock-based compensation 37,245 27,219
Non-cash lease expense 6,865 4,348
Deferred tax 1,774 (4,924)
Change in fair value of contingent consideration liabilities (4,212) 4,353
Change in fair value of financing obligation (3,272) 0
Other (4,415) 609
Changes in operating assets and liabilities, net of business combinations (18,849) 36,125
Net cash provided by operating activities 117,077 117,484
Cash flows from investing activities    
Payments for acquisitions, net of cash acquired (6,825) (548,553)
Proceeds from sale of equity method investment 0 15,100
Purchases of property and equipment (11,711) (7,042)
Other 3,666 2,553
Net cash used in investing activities (14,870) (537,942)
Cash flows from financing activities    
Dividends paid (1,127) (6,329)
Borrowings on debt 0 1,119,300
Repayments of debt (115,899) (483,323)
Deferred financing cost 0 (19,205)
Payments of contingent liabilities (2,864) (8,284)
Taxes paid from net share settlement of restricted stock (5,340) (5,562)
Purchase of treasury shares (3,893) (955)
Other (5,937) 41
Net cash (used in) provided by financing activities (135,060) 595,683
Net (decrease) increase in cash, cash equivalents, and restricted cash (32,853) 175,225
Cash, cash equivalents, and restricted cash, beginning of period 434,045 289,101
Cash, cash equivalents, and restricted cash, end of period 401,192 464,326
Supplemental disclosures of cash flow information    
Cash paid for income taxes   4,728
Cash paid for interest 43,647 30,184
Supplemental disclosures of non-cash investing and financing activities    
Right-of-use assets obtained in exchange for operating lease liabilities 13,969 7,780
Common stock issued for contingent consideration payment 0 2,600
Elimination of note payable upon consolidation 0 9,488
Dividend paid in the form of common stock 0 21,935
Reconciliation of cash, cash equivalents, and restricted cash    
Cash and cash equivalents 396,225 462,227
Restricted cash [1] 4,967 2,099
Total cash, cash equivalents, and restricted cash, end of period shown in the statement of cash flows $ 401,192 $ 464,326
[1] Restricted cash is included in other assets on the condensed consolidated balance sheets.

Source